Associated Papers
Case Report: Complete Response to Nivolumab in a Patient With Programmed Cell Death 1 Ligand 1-Positive and Multiple Gene-Driven Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma.
Dong W et al.
Frontiers in Immunology, 2021
34804000 (PubMed )
Supplement: Table_1.xlsx › Sheet1
Select a paper to view details